{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T12:46:22Z","timestamp":1791636382328,"version":"4.3.4"},"reference-count":28,"publisher":"American Medical Association (AMA)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Cardiol"],"published-print":{"date-parts":[[2020,1,1]]},"DOI":"10.1001\/jamacardio.2019.4534","type":"journal-article","created":{"date-parts":[[2019,11,27]],"date-time":"2019-11-27T16:00:37Z","timestamp":1574870437000},"page":"73","source":"Crossref","is-referenced-by-count":112,"title":["Mortality Among Referral Patients With Hypertrophic Cardiomyopathy vs the General European Population"],"prefix":"10.1001","volume":"5","author":[{"given":"Massimiliano","family":"Lorenzini","sequence":"first","affiliation":[{"name":"Barts Heart Centre, Institute for Cardiovascular Science, St Bartholomew\u2019s Hospital, University College London, London, United Kingdom"},{"name":"Cardiology, Department of Experimental, Diagnostic, and Specialty Medicine, Alma Mater Studiorum University of Bologna, Bologna, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zacharias","family":"Anastasiou","sequence":"additional","affiliation":[{"name":"Department of Statistical Science, University College London, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Constantinos","family":"O\u2019Mahony","sequence":"additional","affiliation":[{"name":"Barts Heart Centre, Institute for Cardiovascular Science, St Bartholomew\u2019s Hospital, University College London, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oliver P.","family":"Guttman","sequence":"additional","affiliation":[{"name":"Barts Heart Centre, Institute for Cardiovascular Science, St Bartholomew\u2019s Hospital, University College London, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan Ramon","family":"Gimeno","sequence":"additional","affiliation":[{"name":"Cardiac Department, University Hospital Virgen Arrixaca, Murcia, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorenzo","family":"Monserrat","sequence":"additional","affiliation":[{"name":"Cardiology Department and Research Unit, A Coru\u00f1a University Hospital, Galician Health Service, A Coru\u00f1a, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aristides","family":"Anastasakis","sequence":"additional","affiliation":[{"name":"Unit of Inherited Cardiovascular Diseases, First Department of Cardiology, University of Athens, Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudio","family":"Rapezzi","sequence":"additional","affiliation":[{"name":"Cardiology, Department of Experimental, Diagnostic, and Specialty Medicine, Alma Mater Studiorum University of Bologna, Bologna, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Biagini","sequence":"additional","affiliation":[{"name":"Cardiology, Department of Experimental, Diagnostic, and Specialty Medicine, Alma Mater Studiorum University of Bologna, Bologna, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pablo","family":"Garcia-Pavia","sequence":"additional","affiliation":[{"name":"Heart Failure and Inherited Cardiac Diseases Unit, Hospital Universitario Puerta del Hierro-Majadahonda, Madrid, Spain"},{"name":"Centro de Investigacion Biomedica en Red en Enfermedades Cardiovasculares, Madrid, Spain"},{"name":"Facultad de Ciencias de la Salud, University Francisco de Vitoria, Pozuelo de Alarc\u00f3n, Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Limongelli","sequence":"additional","affiliation":[{"name":"Department of Cardiothoracic Sciences, Monaldi Hospital, AORN Colli, Universit\u00e0 della Campania \u201cLuigi Vanvitelli,\u201d Naples, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Menelaos","family":"Pavlou","sequence":"additional","affiliation":[{"name":"Department of Statistical Science, University College London, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Perry M.","family":"Elliott","sequence":"additional","affiliation":[{"name":"Barts Heart Centre, Institute for Cardiovascular Science, St Bartholomew\u2019s Hospital, University College London, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"for the Hypertrophic Cardiomyopathy Outcomes investigators","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"12","key":"hoi190080r1","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.1016\/j.jacc.2015.01.019","article-title":"New perspectives on the prevalence of hypertrophic cardiomyopathy.","volume":"65","author":"Semsarian","year":"2015","journal-title":"J Am Coll Cardiol"},{"issue":"6","key":"hoi190080r2","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1136\/hrt.2005.068577","article-title":"Historical trends in reported survival rates in patients with hypertrophic cardiomyopathy.","volume":"92","author":"Elliott","year":"2006","journal-title":"Heart"},{"issue":"24","key":"hoi190080r3","doi-asserted-by":"publisher","first-page":"2317","DOI":"10.1161\/CIRCULATIONAHA.117.027738","article-title":"Perspectives on the overall risks of living with hypertrophic cardiomyopathy.","volume":"135","author":"Maron","year":"2017","journal-title":"Circulation"},{"issue":"5","key":"hoi190080r4","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1161\/CIRCULATIONAHA.112.136085","article-title":"Risk stratification and outcome of patients with hypertrophic cardiomyopathy =60 years of age.","volume":"127","author":"Maron","year":"2013","journal-title":"Circulation"},{"issue":"1","key":"hoi190080r5","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0191214","article-title":"Identifying unmet clinical need in hypertrophic cardiomyopathy using national electronic health records.","volume":"13","author":"Pujades-Rodriguez","year":"2018","journal-title":"PLoS One"},{"issue":"20","key":"hoi190080r6","doi-asserted-by":"publisher","first-page":"2191","DOI":"10.1001\/jama.2013.281053","article-title":"World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects.","volume":"310","author":"World Medical Association","year":"2013","journal-title":"JAMA"},{"issue":"30","key":"hoi190080r7","doi-asserted-by":"publisher","first-page":"2010","DOI":"10.1093\/eurheartj\/eht439","article-title":"A novel clinical risk prediction model for sudden cardiac death in hypertrophic cardiomyopathy (HCM risk-SCD).","volume":"35","author":"O\u2019Mahony","year":"2014","journal-title":"Eur Heart J"},{"issue":"9","key":"hoi190080r9","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1136\/heartjnl-2016-309672","article-title":"Predictors of atrial fibrillation in hypertrophic cardiomyopathy.","volume":"103","author":"Guttmann","year":"2017","journal-title":"Heart"},{"issue":"8","key":"hoi190080r10","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1002\/ejhf.316","article-title":"Prediction of thrombo-embolic risk in patients with hypertrophic cardiomyopathy (HCM Risk-CVA).","volume":"17","author":"Guttmann","year":"2015","journal-title":"Eur J Heart Fail"},{"issue":"2","key":"hoi190080r11","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1136\/hrt.77.2.130","article-title":"Experience from clinical genetics in hypertrophic cardiomyopathy: proposal for new diagnostic criteria in adult members of affected families.","volume":"77","author":"McKenna","year":"1997","journal-title":"Heart"},{"issue":"16","key":"hoi190080r12","doi-asserted-by":"publisher","first-page":"1933","DOI":"10.1093\/eurheartj\/ehl041","article-title":"Left ventricular outflow tract obstruction and sudden death risk in patients with hypertrophic cardiomyopathy.","volume":"27","author":"Elliott","year":"2006","journal-title":"Eur Heart J"},{"issue":"7","key":"hoi190080r13","doi-asserted-by":"publisher","first-page":"2212","DOI":"10.1016\/S0735-1097(00)01003-2","article-title":"Sudden death in hypertrophic cardiomyopathy: identification of high risk patients.","volume":"36","author":"Elliott","year":"2000","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"hoi190080r14","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/0002-9149(76)90491-4","article-title":"Problems in echocardiographic volume determinations: echocardiographic-angiographic correlations in the presence of absence of asynergy.","volume":"37","author":"Teichholz","year":"1976","journal-title":"Am J Cardiol"},{"issue":"13","key":"hoi190080r15","doi-asserted-by":"publisher","first-page":"1703","DOI":"10.1161\/CIRCULATIONAHA.108.798314","article-title":"Syncope and risk of sudden death in hypertrophic cardiomyopathy.","volume":"119","author":"Spirito","year":"2009","journal-title":"Circulation"},{"issue":"5","key":"hoi190080r16","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1016\/S0735-1097(03)00827-1","article-title":"Non-sustained ventricular tachycardia in hypertrophic cardiomyopathy: an independent marker of sudden death risk in young patients.","volume":"42","author":"Monserrat","year":"2003","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"hoi190080r17","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/S0735-1097(02)02713-4","article-title":"Maximum left ventricular thickness and risk of sudden death in patients with hypertrophic cardiomyopathy.","volume":"41","author":"Olivotto","year":"2003","journal-title":"J Am Coll Cardiol"},{"issue":"4","key":"hoi190080r18","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1056\/NEJMoa021332","article-title":"Effect of left ventricular outflow tract obstruction on clinical outcome in hypertrophic cardiomyopathy.","volume":"348","author":"Maron","year":"2003","journal-title":"N Engl J Med"},{"issue":"5","key":"hoi190080r19","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1016\/j.amjcard.2009.04.039","article-title":"Left ventricular outflow tract obstruction as a risk factor for sudden cardiac death in hypertrophic cardiomyopathy.","volume":"104","author":"Efthimiadis","year":"2009","journal-title":"Am J Cardiol"},{"issue":"39","key":"hoi190080r22","doi-asserted-by":"publisher","first-page":"2733","DOI":"10.1093\/eurheartj\/ehu284","article-title":"2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy: the Task Force for the Diagnosis and Management of Hypertrophic Cardiomyopathy of the European Society of Cardiology (ESC).","volume":"35","author":"Elliott","year":"2014","journal-title":"Eur Heart J"},{"issue":"1","key":"hoi190080r23","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1161\/CIRCULATIONAHA.115.017633","article-title":"Hypertrophic cardiomyopathy in children, adolescents, and young adults associated with low cardiovascular mortality with contemporary management strategies.","volume":"133","author":"Maron","year":"2016","journal-title":"Circulation"},{"issue":"18","key":"hoi190080r24","doi-asserted-by":"publisher","first-page":"1915","DOI":"10.1016\/j.jacc.2015.02.061","article-title":"Hypertrophic cardiomyopathy in adulthood associated with low cardiovascular mortality with contemporary management strategies.","volume":"65","author":"Maron","year":"2015","journal-title":"J Am Coll Cardiol"},{"issue":"14","key":"hoi190080r25","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.1161\/CIRCULATIONAHA.117.033200","article-title":"Genotype and lifetime burden of disease in hypertrophic cardiomyopathy: insights from the Sarcomeric Human Cardiomyopathy Registry (SHaRe).","volume":"138","author":"Ho","year":"2018","journal-title":"Circulation"},{"issue":"46","key":"hoi190080r26","doi-asserted-by":"publisher","first-page":"3434","DOI":"10.1093\/eurheartj\/ehx527","article-title":"Women with hypertrophic cardiomyopathy have worse survival.","volume":"38","author":"Geske","year":"2017","journal-title":"Eur Heart J"},{"issue":"7","key":"hoi190080r27","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0102969","article-title":"Female sex is associated with worse prognosis in patients with hypertrophic cardiomyopathy in China.","volume":"9","author":"Wang","year":"2014","journal-title":"PLoS One"},{"issue":"3","key":"hoi190080r28","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1016\/j.jacc.2005.04.043","article-title":"Gender-related differences in the clinical presentation and outcome of hypertrophic cardiomyopathy.","volume":"46","author":"Olivotto","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"hoi190080r21","volume-title":"Statistical Methods in Epidemiology","author":"Kahn","year":"1989"},{"key":"hoi190080r8","unstructured":"HCMRisk.org. Hypertrophic Cardiomyopathy Outcomes Investigators. http:\/\/www.HCMRisk.org. Accessed October 14, 2019."},{"key":"hoi190080r20","unstructured":"Eurostat. Your key to European statistics. https:\/\/ec.europa.eu\/eurostat\/web\/main\/home. Accessed November 15, 2017."}],"container-title":["JAMA Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamacardiology\/articlepdf\/2756248\/jamacardiology_lorenzini_2019_oi_190080.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,1,15]],"date-time":"2020-01-15T17:21:45Z","timestamp":1579108905000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamacardiology\/fullarticle\/2756248"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1,1]]},"references-count":28,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,1,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamacardio.2019.4534","relation":{},"ISSN":["2380-6583"],"issn-type":[{"value":"2380-6583","type":"print"}],"subject":[],"published":{"date-parts":[[2020,1,1]]}}}